Improved survival time trends for glioblastoma using the SEER 17 population-based registries (Q33828439)

29 July 2017

title

Improved survival time trends for glioblastoma using the SEER 17 population-based registries (English)

1 reference

29 July 2017

1 reference

Matthew Koshy

1

0 references

author name string

John L Villano

2

1 reference

29 July 2017

Therese A Dolecek

3

1 reference

29 July 2017

Andrew Howard

4

1 reference

29 July 2017

Usama Mahmood

5

1 reference

29 July 2017

Steven J Chmura

6

1 reference

29 July 2017

Ralph R Weichselbaum

7

1 reference

29 July 2017

Bridget J McCarthy

8

1 reference

29 July 2017

publication date

9 October 2011

1 reference

Journal of Neuro-Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

107

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

207-212

1 reference

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Survival comparison between glioblastoma multiforme and other incurable cancers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

NCI SEER public-use data: applications and limitations in oncology research.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Optimal role of temozolomide in the treatment of malignant gliomas.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Factors influencing survival in high-grade gliomas

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Radiosurgical boost for primary high-grade gliomas

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

4 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

Functional outcome after language mapping for glioma resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

Multivariate analysis of prognostic factors in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0738-7

21 January 2018

Resection and prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4077033

29 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21984115

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21984115

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-011-0738-7

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference